Reconsidering milrinone: Time to revive the oral form for drug repurposing?

  • Fatemeh Afra Department of Clinical Pharmacy, School of Pharmacy, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Elahe Shaban Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Amirmahdi Mojtahedzadeh School of Medicine, Semmelweis University, Budapest, Hungary
  • Mojtaba Mojtahedzadeh Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
DOI: https://doi.org/10.18502/cjn.v24i3.21605
Keywords: Milrinone; Phosphodiesterase 3 Inhibitors; Neuroprotective Agents; Subarachnoid Hemorrhage

Abstract

The Article Abstract is not available.
Published
2026-05-30
Issue
Volume (24) issue (3)
Section
Articles